Received May 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | OT |
Consumer calling to report that they did not receive their 2nd and 3rd dose of GARDASIL 9. Patient did not report any side effects. Permission to contact HCP was not given. No Additional AE/ No PQC; No adverse event; This spontaneous report was received from a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On an unknown date, the patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL9), administered by intravenous route (dose, anatomical location, lot # and expiration date were not reported) as HPV vaccine. It was reported that the patient did not receive their 2nd and 3rd dose of the suspect vaccine (incomplete course of vaccination). In addition, the patient did not report any side effects. Additional information is not expected.